Regentree LLC

Ophthalmology

Regentree LLC focuses on ophthalmology with an emphasis on conditions affecting the corneal surface and visual function. Its active clinical research is centered on neurotrophic keratopathy, a disorder associated with impaired corneal healing and reduced corneal sensitivity.

  • Corneal disease
  • Ocular surface disorders
  • Neurotrophic keratopathy

The sponsor’s trial portfolio reflects a targeted interest in treatments for persistent corneal damage and related eye health complications.

Corneal Repair and Healing

Its research activity includes therapies aimed at supporting corneal repair and restoring the integrity of damaged ocular tissue. The clinical studies address therapeutic approaches for patients with compromised healing of the cornea.

  • Corneal epithelial healing
  • Corneal integrity
  • Ocular surface restoration

This area highlights a therapeutic interest in interventions designed for chronic corneal injury and loss of protective sensation.

Rare Eye Disorders

Regentree LLC’s clinical research landscape includes attention to a rare eye disorder with limited treatment options. The sponsor is engaged in studies that address the unmet needs of patients living with uncommon corneal conditions.

  • Rare ocular disease
  • Unmet ophthalmic need
  • Vision-threatening corneal conditions

The funded research is directed toward improving care for a specialized patient population affected by progressive corneal dysfunction.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Safety and Effectiveness of Timbetasin Acetate Eye Drops for Patients with Neurotrophic Keratopathy

    Recruiting

    1 1
    Investigated drugs:
    Italy Poland Spain
  • Study on the Safety and Effectiveness of RGN-259 Eye Drops for Patients with Neurotrophic Keratopathy

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Poland Spain